Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

3.18
+0.330011.58%
Post-market: 3.15-0.0300-0.94%19:56 EDT
Volume:695.58K
Turnover:2.11M
Market Cap:7.59M
PE:-0.01
High:3.19
Open:2.87
Low:2.80
Close:2.85
Loading ...
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 25, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2020

Major Issues Report

8-K - Current report
Sep 16, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 15, 2020

Major Issues Report

8-K - Current report
Aug 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 14, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]